Search Results
Results found for "Institute for Research in Immunology and Cancer"
- Amgen to Acquire Chemocentryx for $4 Billion in Cash
focused on orally administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer
- Dr. Adriano Marchese - Dr. GPCR Podcast
Learn about his remarkable career and research in #GPCR signaling and trafficking.
- Integrated GPCR Drug Discovery: A Structured Framework for Modern Programs
Institutional and team memberships receive discounted rates to support coordinated participation.
- Michel Bouvier appointed Knight of the Ordre national du Québec
Michel Bouvier, Chief Executive Officer of IRIC, Principal Investigator of the Molecular Pharmacology Research
- Decoding Schild Analysis: The Pharmacologist’s Lens on Competitive Antagonism
Inverse Agonists and Hemi-Equilibria In systems with constitutive receptor activity , inverse agonists It encourages skepticism—forcing researchers to prove competition before quantifying it.
- GPCR Therapeutics Expands Scientific Advisory Board
Jon Wigginton will provide scientific expertise to support the company’s research and clinical development
- Domain Therapeutics Raises $42m Series A Financing
STRASBOURG, France & MONTREAL- Domain Therapeutics, a biopharmaceutical company specializing in the research
- 📰 GPCR Weekly News, June 19 to 25, 2023
Methods & Updates in GPCR Research A coiled-coil-based design strategy for the thermostabilization of the Gliovascular Unit of Glioblastoma Associate Director / Director, Clinical Operations Postdoctoral Research
- Exploring pharmacological inhibition of G q/11 as an analgesic strategy
Previous research showed that activation of Gq/11 proteins by G-protein coupled receptors has pro-nociceptive
- Pharmacology at Your Fingertips: Terry’s Corner Launches
GPCR partner Celtarys Research has validated a TR-FRET assay for cannabinoid receptor ligands using their
- Hear the sounds: the role of G protein-coupled receptors in the cochlea
The research of GPCRs in the cochlea is essential for the understanding of the cochlea development, hearing
- Regulators of G-protein signaling: essential players in GPCR signaling
has been implicated in a range of diseases, including cardiovascular disease, pain, hypertension, and cancer While in cancer, RGS proteins are involved in regulating cell proliferation and survival[8]. al., Identification of a five-gene signature of the RGS gene family with prognostic value in ovarian cancer
- C3aR plays both sides in regulating resistance to bacterial infections
Specifically, previous research has identified mechanistically distinct and cell type–specific roles
- 📰 GPCR Weekly News, January 16 to 22, 2023
Keep up-to-date with the latest research and advancements in the field with our convenient, weekly news Methods & Updates in GPCR Research Mapping of structural arrangement of cells and collective calcium
- Dopamine D 1 receptor-mediated β-arrestin signaling: Insight from pharmacology, biology, behavior...
importance of functional selectivity/biased signaling has led to the discovery of biased compounds as both research
- 📰 GPCR Weekly News - January 9 to 15, 2023
Keep up-to-date with the latest research and advancements in the field with our convenient, weekly news first-line treatment The Lundbeck Foundation is awarding DKK 174 million in grants to seven ‘mind-bending’ research
- Immunomodulatory Role of Neuropeptides in the Cornea
As research in this area expands, further insights are made into the role of neuropeptides and their
- SLAS2022 International Conference and Exhibition
Don't miss the chance to present your innovative research at this year's conference.
- Activation of the human chemokine receptor CX3CR1 regulated by cholesterol
endogenous ligand CX3CL1, which shows notable potential as a therapeutic target in atherosclerosis, cancer
- Exscientia is 10 years old this July!
platform clinically validated to guide treatment selection in patients with advanced haematological cancers
- Ode to GPCRs
weeks of the month, the Royal Swedish Academy of Sciences and the Nobel Assembly at the Karolinska Institute Therefore, the presentation of 10 or more Nobel prizes highlights the importance of research work on the primary physiological and chemical visual processes in the eye.[7–11] Through Nobel prize-winning research Prize in Physiology or Medicine went to Eric Richard Kandel, Arvid Carlsson, and Paul Greengard for research Therefore, we envision that this field will continue to produce high-impact research work that will garner
- 4GPCRnet - International Symposium
Four of the biggest European networks on GPCR research (COST Actions Adher’n Rise and ERNEST plus DFG-funded
- Comparative study of neuropeptide signaling systems in Hemiptera
This research provides more knowledge on neuropeptide systems and sets the groundwork for the creation
- Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR
City-based Kallyope, pioneers in drug discovery involving the gut-brain axis, have entered a strategic research
- GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for...
receptor (A2AAR) have been considered promising agents to treat Parkinson's disease, inflammation, cancer
- Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology
exclusivity on data related to GPCR implicated in immunoresistance, to develop first-in class innovative cancer
- RAB-Symposium - Regulatory Autoantibodies Targeting GPCRs. September 15-16, 2022. Lübeck, Germany...
have been developed, with a focus on small molecules and monoclonal antibodies for the treatment of cancer
- All About Addgene: More Open and Reproducible Science with Materials Sharing
If you need a plasmid for your research or you want to share your materials, this is the place to go.
- GPCR Drug Discovery Summit 2026: What to Expect in Boston — and How to Register
Discovery Experts to Watch (coming soon) In the run-up to the summit, we're speaking with some of the researchers
- Successful prednisolone or calcimimetic treatment of acquired hypocalciuric hypercalcemia caused...
hypercalcemia caused by biased allosteric CaSR autoantibodies "Biased agonism is a frontier field in GPCR research







